AstraZeneca receives positive NICE recommendations for lung cancer treatment
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence ...
Tag: Non-Small Cell Lung Cancer
Immunotherapy yields complete response in stage IV lung cancer
A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, "Complete and long-lasting response to immunotherapy in a ...
AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the ...
Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC
The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment ...
AI-based body composition analysis predicts lung cancer treatment outcomes
Tafadzwa Chaunzwa, MD, a researcher in the Artificial Intelligence in Medicine (AIM) Program at Mass General Brigham and a senior ...
New understanding of lung cancer cells' 'memories' suggests novel treatment approach
A new understanding of lung cancer cells' "memories" suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center ...
Liquid biopsies could be used as an early marker of immunotherapy response, study finds
Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream ...
Early smoking cessation associated with higher survival rates following a lung cancer diagnosis
Quitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new study led ...
Immunochemistry multiplex for solid tumor analytical validation
Sponsored Content by Cerba ResearchMar 16 2023Reviewed by Louis Castel Accurately characterizing the tumor micro-environment when tissue sample access is ...
Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients
Bottom line: Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free ...
